CANY
CVS icon

Caxton Associates (New York)’s CVS Health CVS Stock Holding History

Caxton Associates (New York)’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-9,811
Closed -$617K – 531
2024
Q3 		$617K Buy
+9,811
New +$572K 0.02% 330
2023
Q3 		– Sell
-8,926
Closed -$617K – 448
2023
Q2 		$617K Sell
8,926
-696
-7% -$49.5K 0.09% 229
2023
Q1 		$715K Buy
9,622
+1,607
+20% +$135K 0.11% 203
2022
Q4 		$747K Buy
+8,015
New +$773K 0.05% 169
2021
Q2 		– Sell
-10,120
Closed -$761K – 488
2021
Q1 		$761K Buy
+10,120
New +$737K 0.07% 100
2020
Q3 		– Sell
-6,453
Closed -$419K – 352
2020
Q2 		$419K Buy
6,453
+143
+2% +$9.01K 0.04% 172
2020
Q1 		$374K Sell
6,310
-70,390
-92% -$4.7M 0.07% 213
2019
Q4 		$5.7M Buy
+76,700
New +$5.39M 0.78% 21
2018
Q3 		– Sell
-6,542
Closed -$421K – 427
2018
Q2 		$421K Sell
6,542
-10,703
-62% -$705K 0.02% 266
2018
Q1 		$1.07M Buy
17,245
+2,502
+17% +$180K 0.05% 178
2017
Q4 		$1.07M Buy
14,743
+10,943
+288% +$796K 0.05% 200
2017
Q3 		$309K Buy
+3,800
New +$301K 0.01% 429
2015
Q2 		– Sell
-4,000
Closed -$413K – 161
2015
Q1 		$413K Buy
+4,000
New +$405K 0.02% 151
2013
Q3 		– Sell
-45,000
Closed -$2.57M – 176
2013
Q2 		$2.57M Buy
+45,000
New +$2.61M 0.13% 105

Other funds holding CVS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Pzena Investment Management
Pzena Investment Management New York $30.8B AUM 11.29% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

Caxton Associates (New York)'s CVS Position: Q4 2024 in Review

Caxton Associates (New York) sold out of CVS Health (CVS) in Q4 2024, closing a stake of 9,811 shares — an estimated $617K sold.

Caxton Associates (New York) first reported a position in CVS in Q2 2013 and held it in 14 quarters. The position peaked at $5.7M in Q4 2019. 1,668 funds tracked by Wall St. Rank hold CVS as of Q4 2024.

  • Caxton Associates (New York) reported no remaining CVS Health position as of Q4 2024 after selling out during the quarter.
  • Caxton Associates (New York) sold 9,811 CVS Health shares in Q4 2024, an estimated $617K.
  • Caxton Associates (New York) first reported a position in CVS Health in Q2 2013 and held it in 14 quarters.
  • Caxton Associates (New York)'s CVS Health position peaked at $5.7M in Q4 2019.
  • 1,668 funds tracked by Wall St. Rank held CVS Health as of Q4 2024.

Based on Caxton Associates (New York)'s 13F filing for Q4 2024, filed 14 Feb 2025.